Gladius Capital Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,383
| Closed | -$46.1K | – | 286 |
|
|
2024
Q1 | $46.1K | Buy |
3,383
+252
| +8% | +$3.44K | 0.02% | 128 |
|
|
2023
Q4 | $34.3K | Buy |
3,131
+1,026
| +49% | +$11.2K | 0.01% | 172 |
|
|
2023
Q3 | $23.1K | Buy |
2,105
+813
| +63% | +$8.9K | ﹤0.01% | 242 |
|
|
2023
Q2 | $17.1K | Sell |
1,292
-424
| -25% | -$5.61K | ﹤0.01% | 224 |
|
|
2023
Q1 | $23.4K | Sell |
1,716
-119
| -6% | -$1.62K | ﹤0.01% | 234 |
|
|
2022
Q4 | $35.8K | Buy |
1,835
+249
| +16% | +$4.86K | ﹤0.01% | 213 |
|
|
2022
Q3 | $31K | Buy |
+1,586
| New | +$31K | ﹤0.01% | 241 |
|